MSB 4.07% $1.15 mesoblast limited

Why a trial?, page-30

  1. 4,173 Posts.
    lightbulb Created with Sketch. 5439
    I pose a question to you

    "And if any did - irrespective of what happens with the other two potency assay items - I think that would be a cause for concern - and MSB have themselves posted at least one example where INF alpha levels did increase after a batch of MSCs were added to a mix.

    INF gamma - once called macrophage activating factor - would be something Matt Klinker would be inclined to look for. He has seen it used to prime MSCs and has used it that way himself."


    What happens if a patient who has a MAP score > 0.29 recieves an INF Gamma increasing MSC, and then survives?
    Currently there is no in Vivo evidence that a cell that does or even does not decrease Inf Gamma has any effect on survival - so you are postulating that an unproven hypothetical would cause concern over what is now becoming proven in Vivo survival data?
    One is theoretical, the other is practical data.

    One can reduce IL2R alpha by around 80%, the other in contrast cause minor increases and decreases to INF Gamma < 30%.




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.